Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases

Recs

1
Player Avatar getrichslowfool (< 20) Submitted: 1/13/2012 3:21:38 PM : Outperform Start Price: $12.32 ACHN Score: -43.49

Yeah it's run up a bunch recently, but I think IDIX will get bought out and this will run up more with it. Time will tell

Featured Broker Partners


Advertisement